2023. Evaluation of the use of CGRP monoclonal antibodies (mAbs) in migraine prophylaxis in a private clinic. Headache Medicine. 14, 2 (Jun. 2023), 83–88. DOI:https://doi.org/10.48208/HeadacheMed.2023.17.